MedPath
HSA Approval

OXACIL GRANULES 125MG/5ML

SIN09934P

OXACIL GRANULES 125MG/5ML

OXACIL GRANULES 125MG/5ML

August 5, 1998

DUOPHARMA (SINGAPORE) PTE LTD

DUOPHARMA (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDUOPHARMA (SINGAPORE) PTE LTD
Licence HolderDUOPHARMA (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

GRANULE, FOR SUSPENSION

ORAL

Medical Information

J01CF02

cloxacillin

Manufacturer Information

DUOPHARMA (SINGAPORE) PTE. LTD.

DUOPHARMA (M) SDN BHD

Active Ingredients

CLOXACILLIN SODIUM EQV CLOXACILLIN

125 mg/5 ml

Cloxacillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OXACIL GRANULES 125MG/5ML - HSA Approval | MedPath